PATH trades against a final fair-value range of $8.05-$13.97, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $8.05, high $14.0, with mid-point at $11.0.
Trades close to fair value, so the margin of safety is limited either way.
Fair value
$11
Margin of safety
+1.7%
Confidence
84/100
Moat
6.5/10
Educational research only - not investment advice, an offer, or a trade instruction. Confirm current data and do your own due diligence before acting.
$10.79Price
Low $8.05
Mid $10.98
High $13.97
PATH trades against a final fair-value range of $8.05-$13.97, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.
High switching costs embedded deep
High switching costs embedded deep within enterprise legacy workflows.
Incumbent scale and broad integrations
Incumbent scale and broad integrations in traditional RPA markets.
Cycle upside
Enterprise AI adoption drives massive structural process orchestration needs across sectors.
Our financial-history view of PATH (PATH) covers revenue, gross profit, operating income, and net income across the past five fiscal years, with year-over-year growth and margin context for each line.
The revenue trajectory is reported in the financial-history section with year-over-year growth rates. Direction and acceleration are summarised inline; the full table sits within the parent financials tab.
We track operating income alongside operating margin so the reader can separate top-line growth from operating leverage. The numbers analysis subsection flags one-offs, restructuring, and stock-based-compensation effects when material.
Net income is shown together with EPS so dilution and buybacks are visible alongside profit. Where reported net income diverges materially from operating cash flow, the discrepancy is called out in the numbers-analysis subsection.
FAQ
PATH — frequently asked questions
Based on our latest analysis, PATH trades close to fair value. The current price is $10.8 versus a composite fair-value midpoint of $11.0 (range $8.05–$14.0), which implies roughly 1.8% upside to the midpoint.
Our composite fair-value range for PATH is $8.05–$14.0, with a midpoint of $11.0. The range is triangulated across multiple valuation models (discounted earnings, forward earnings scenarios, peer multiples, and where applicable owner earnings or reverse DCF) and weighted by reliability for PATH's archetype.
Our current rating for PATH is Hold with a confidence score of 84/100. PATH is rated Hold at $10.79 versus the reconciled fair value midpoint of $10.98, implying +1.76% upside/downside. Confidence is separately disclosed at 84/100. This is research for educational purposes, not personalized investment advice.
The top risks our latest report flags for PATH are: AI Generative Disruption; Structural Margin Stagnation; Uncontrolled SBC Escalation. The single biggest risk is AI Generative Disruption: Generative AI agents bypass traditional RPA workflows entirely, collapsing gross margins and pipeline growth.
Our current rating for PATH is Hold, issued with a confidence score of 84/100 and a moat score of 6.5/10. The rating reflects the composite fair-value range ($8.05–$14.0) versus the current price of $10.8.
PATH is classified as a mature compounder stock. Archetype determines how every downstream parameter — discount rate, terminal growth, deceleration curve, terminal multiple, scenario probability weights, scorecard weights, and which valuation models are prioritized — is calibrated for PATH.